Видео ютуба по тегу Humacyte

Durham company growing blood vessels from human cells
Durham company growing blood vessels from human cells
Breakthroughs in Vascular Surgery
Breakthroughs in Vascular Surgery
HUMACYTE Stock: Defense Department Bill Inclusion Could Be a Game Changer
HUMACYTE Stock: Defense Department Bill Inclusion Could Be a Game Changer
Humacyte: Durham Company Seeks FDA Approval for Life-Saving Product
Humacyte: Durham Company Seeks FDA Approval for Life-Saving Product
Dr. Laura Niklason, Founder, Humacyte, 2017
Dr. Laura Niklason, Founder, Humacyte, 2017
My take on Humacyte's 8-K: Lifeline or just more paper?
My take on Humacyte's 8-K: Lifeline or just more paper?
My Take on Humacyte's 8-K: A Confidence Signal?
My Take on Humacyte's 8-K: A Confidence Signal?
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Обзор доходов Humacyte #HUMA 12 ноября
Обзор доходов Humacyte #HUMA 12 ноября
Why Humacyte Is Going Public Via SPAC
Why Humacyte Is Going Public Via SPAC
Humacyte: Surgeons call Humacytes ATEV product Revolutionary!!!
Humacyte: Surgeons call Humacytes ATEV product Revolutionary!!!
Могут ли новые данные Humacyte принести прибыль? Революционное биотехнологическое оповещение! #HUMA
Могут ли новые данные Humacyte принести прибыль? Революционное биотехнологическое оповещение! #HUMA
🎯𝗛𝗨𝗠𝗔𝗖𝗬𝗧𝗘'𝗦 𝗙𝗗𝗔 𝗔𝗣𝗣𝗥𝗢𝗩𝗔𝗟: 𝗧𝗛𝗘 𝗩𝗔𝗦𝗖𝗨𝗟𝗔𝗥 𝗚𝗥𝗔𝗙𝗧 𝗥𝗘𝗩𝗢𝗟𝗨𝗧𝗜𝗢𝗡 𝗛𝗔𝗦 𝗔𝗥𝗥𝗜𝗩𝗘𝗗
🎯𝗛𝗨𝗠𝗔𝗖𝗬𝗧𝗘'𝗦 𝗙𝗗𝗔 𝗔𝗣𝗣𝗥𝗢𝗩𝗔𝗟: 𝗧𝗛𝗘 𝗩𝗔𝗦𝗖𝗨𝗟𝗔𝗥 𝗚𝗥𝗔𝗙𝗧 𝗥𝗘𝗩𝗢𝗟𝗨𝗧𝗜𝗢𝗡 𝗛𝗔𝗦 𝗔𝗥𝗥𝗜𝗩𝗘𝗗
Акции HUMA (акции Humacyte) ПРОГНОЗ АКЦИЙ HUMA Анализ АКЦИЙ HUMA Новости акций HUMA сегодня
Акции HUMA (акции Humacyte) ПРОГНОЗ АКЦИЙ HUMA Анализ АКЦИЙ HUMA Новости акций HUMA сегодня
Humacyte's Bioengineered Vessel: A Potential Game-Changer for Hemodialysis Access
Humacyte's Bioengineered Vessel: A Potential Game-Changer for Hemodialysis Access
Humacyte, Inc HUMA Q3 2025 Earnings Call
Humacyte, Inc HUMA Q3 2025 Earnings Call
068 Биоинженерные сосудистые трансплантаты - Биоинженерные кровеносные сосуды
068 Биоинженерные сосудистые трансплантаты - Биоинженерные кровеносные сосуды
Acellular Tissue Engineered Vessel for Hemodialysis Access
Acellular Tissue Engineered Vessel for Hemodialysis Access
Global Kidney Voices™: Kidney Patients Driving Global Innovation & Independence (Humacyte)
Global Kidney Voices™: Kidney Patients Driving Global Innovation & Independence (Humacyte)
Humacyte Inc - HUMA #invest #stocks
Humacyte Inc - HUMA #invest #stocks
Just SAD! Humacyte HUMA Stock Analysis | Software vs. Biotech Investing | Martin Shkreli
Just SAD! Humacyte HUMA Stock Analysis | Software vs. Biotech Investing | Martin Shkreli
$AHAC Humacyte CEO Dr. Laura Niklason Investor Presentation March 2021
$AHAC Humacyte CEO Dr. Laura Niklason Investor Presentation March 2021
Humacyte (HUMA|$213.8M) - 2025 Q3 Earnings Analysis
Humacyte (HUMA|$213.8M) - 2025 Q3 Earnings Analysis
Investing in the future of regenerative medicine
Investing in the future of regenerative medicine